共 50 条
Expanding Family Health History to Include Family Medication History
被引:0
|作者:
Haga, Susanne B.
[1
]
Orlando, Lori A.
[1
]
机构:
[1] Duke Univ, Sch Med, Dept Med, Durham, NC 27708 USA
来源:
关键词:
family health history;
medication history;
pharmacogenetic testing;
REPORTED OUTCOME MEASURES;
MALIGNANT HYPERTHERMIA;
PRIMARY-CARE;
CANCER-RISK;
ANESTHETIC DEATHS;
WEIGHT-GAIN;
VALIDATION;
MUTATION;
IMPACT;
TOOL;
D O I:
10.3390/jpm13030410
中图分类号:
R19 [保健组织与事业(卫生事业管理)];
学科分类号:
摘要:
The collection of family health history (FHH) is an essential component of clinical practice and an important piece of data for patient risk assessment. However, family history data have generally been limited to diseases and have not included medication history. Family history was a key component of early pharmacogenetic research, confirming the role of genes in drug response. With the substantial number of known pharmacogenes, many affecting response to commonly prescribed medications, and the availability of clinical pharmacogenetic (PGx) tests and guidelines for interpretation, the collection of family medication history can inform testing decisions. This paper explores the roots of family-based pharmacogenetic studies to confirm the role of genes in these complex phenotypes and the benefits and challenges of collecting family medication history as part of family health history intake.
引用
收藏
页数:8
相关论文